Journal article
Discover Mental Health, 2022
APA
Click to copy
Steenblock, C., Schwarz, P., Perakakis, N., Brajshori, N., Beqiri, P., & Bornstein, S. (2022). The interface of COVID-19, diabetes, and depression. Discover Mental Health.
Chicago/Turabian
Click to copy
Steenblock, C., P. Schwarz, Nikolaos Perakakis, Naime Brajshori, Petrit Beqiri, and S. Bornstein. “The Interface of COVID-19, Diabetes, and Depression.” Discover Mental Health (2022).
MLA
Click to copy
Steenblock, C., et al. “The Interface of COVID-19, Diabetes, and Depression.” Discover Mental Health, 2022.
BibTeX Click to copy
@article{c2022a,
title = {The interface of COVID-19, diabetes, and depression},
year = {2022},
journal = {Discover Mental Health},
author = {Steenblock, C. and Schwarz, P. and Perakakis, Nikolaos and Brajshori, Naime and Beqiri, Petrit and Bornstein, S.}
}
Comorbid diabetes with depression is a challenging and often under-recognized clinical problem. During the current COVID-19 pandemic, a communicable disease is thriving on the increasing incidences of these non-communicable diseases. These three different health problems are bidirectionally connected forming a vicious cycle. Firstly, depressed individuals show a higher risk of developing diabetes and patients with diabetes have a higher risk of developing symptoms of depression. Secondly, patients with diabetes have a higher risk of developing severe COVID-19 as well as of experiencing breakthrough infections. Thirdly, in both patients with type 2 diabetes and in COVID-19 survivors the prevalence of depression seems to be increased. Fourthly, lockdown and quarantine measurements during the COVID-19 pandemic has led to an increase in depression. Therefore, it is of importance to increase the awareness of this interface between depression, diabetes and COVID-19. Finally, as symptoms of post-COVID, diabetes and depression may be overlapping, there is a need for educating skilled personnel in the management of these comorbidities.